Werbung
Werbung
LTRN
Lantern Pharma Inc. Common Stock
3.41
USDGesponsert
-0.04
-1.16%
07. Jan., 15:58 UTC -5
Geschlossen
Nach-Markt
3.46
+0.05
+1.44%
LTRN Ergebnisberichte
Positives Überraschungsverhältnis
LTRN übertreffen die 16 der letzten 21Schätzungen.
76%
Nächster Bericht
Datum des nächsten Berichts
25. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.46
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/+17.95%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-14.81%
Lantern Pharma Inc. Common Stock earnings per share and revenue
On 12. Nov. 2025, LTRN reported earnings of -0.39 USD per share (EPS) for Q3 25, beating the estimate of -0.47 USD, resulting in a 18.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.57% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.46 USD, with revenue projected to reach -- USD, implying an increase of 17.95% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Lantern Pharma Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Lantern Pharma Inc. Common Stock reported EPS of -$0.39, beating estimates by 18.65%, and revenue of $0.00, 0% as expectations.
How did the market react to Lantern Pharma Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -0.57%, changed from $3.48 before the earnings release to $3.46 the day after.
When is Lantern Pharma Inc. Common Stock expected to report next?
The next earning report is scheduled for 25. März 2026.
What are the forecasts for Lantern Pharma Inc. Common Stock's next earnings report?
Based on 3
analysts, Lantern Pharma Inc. Common Stock is expected to report EPS of -$0.46 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung